Genome Engineering Organ Transplant Market

In the Genome Engineering Organ Transplant Market, the largest technology share in 2026 is held by CRISPR-Cas9 Gene Editing, at 31.1%. The Kidney segment leads by organ type with 33.2%. By application, 34.0% is attributed to Xenotransplantation.